GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Cyclically Adjusted FCF per Share

SEEGENE (XKRX:096530) Cyclically Adjusted FCF per Share : ₩1,722.67 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is SEEGENE Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

SEEGENE's adjusted free cash flow per share for the three months ended in Mar. 2025 was ₩958.056. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩1,722.67 for the trailing ten years ended in Mar. 2025.

During the past 12 months, SEEGENE's average Cyclically Adjusted FCF Growth Rate was 12.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 29.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 139.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of SEEGENE was 366.50% per year. The lowest was 29.00% per year. And the median was 92.70% per year.

As of today (2025-05-31), SEEGENE's current stock price is ₩33500.00. SEEGENE's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₩1,722.67. SEEGENE's Cyclically Adjusted Price-to-FCF of today is 19.45.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of SEEGENE was 15218.51. The lowest was 13.05. And the median was 29.64.


SEEGENE Cyclically Adjusted FCF per Share Historical Data

The historical data trend for SEEGENE's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SEEGENE Cyclically Adjusted FCF per Share Chart

SEEGENE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 207.87 746.76 1,293.02 1,487.21 1,603.31

SEEGENE Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,532.70 1,549.29 1,623.80 1,603.31 1,722.67

Competitive Comparison of SEEGENE's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, SEEGENE's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SEEGENE's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SEEGENE's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where SEEGENE's Cyclically Adjusted Price-to-FCF falls into.


;
;

SEEGENE Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SEEGENE's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=958.056/122.5900*122.5900
=958.056

Current CPI (Mar. 2025) = 122.5900.

SEEGENE Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 2.001 100.051 2.452
201509 -51.002 100.111 -62.454
201512 -123.467 100.220 -151.025
201603 -4.421 100.561 -5.389
201606 37.554 100.791 45.676
201609 62.255 101.461 75.219
201612 17.732 101.561 21.403
201703 86.394 102.851 102.975
201706 -59.989 102.611 -71.669
201709 3.105 103.491 3.678
201712 38.125 102.991 45.380
201803 89.019 104.101 104.830
201806 18.354 104.130 21.608
201809 65.267 105.651 75.732
201812 19.902 104.351 23.381
201903 149.648 104.491 175.569
201906 119.475 104.881 139.648
201909 66.480 105.200 77.469
201912 94.318 105.121 109.991
202003 -78.922 105.354 -91.834
202006 666.765 105.112 777.636
202009 93.442 106.198 107.865
202012 1,278.538 105.765 1,481.921
202103 59.942 107.357 68.447
202106 92.878 107.579 105.838
202109 3,167.098 108.759 3,569.855
202112 1,804.074 109.676 2,016.491
202203 4,638.049 111.848 5,083.492
202206 -16.537 114.072 -17.772
202209 -180.219 114.715 -192.590
202212 325.908 115.179 346.877
202303 569.705 116.507 599.448
202306 75.558 117.182 79.045
202309 269.951 118.964 278.180
202312 391.040 118.837 403.389
202403 184.386 120.123 188.172
202406 254.472 120.007 259.949
202409 635.139 120.861 644.224
202412 -172.438 121.135 -174.509
202503 958.056 122.590 958.056

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


SEEGENE  (XKRX:096530) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

SEEGENE's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=33500.00/1722.67
=19.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of SEEGENE was 15218.51. The lowest was 13.05. And the median was 29.64.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


SEEGENE Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of SEEGENE's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


SEEGENE Business Description

Industry
Traded in Other Exchanges
N/A
Address
Taewon Building 65-5 Bangyi-Dong, Songpa-gu, Seoul, KOR, 138-050
SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.

SEEGENE Headlines

No Headlines